the authors have devised a continuous fluorescence-based assay to measure hIV reverse transcriptase (rt) polymerase activity for both high-throughput screening (htS) and mechanistic characterization of inhibitors. the designed substrate is composed of a recessed DnA primer annealed to a DnA template that is labeled at the 5′-terminus with a donor fluorophore (AlexaFluor 488). rt-catalyzed incorporation of an acceptor-labeled deoxyuridine (dUtp-AlexaFluor 555) at the 3′-terminus of the fully extended DnA primer juxtaposes donor and acceptor fluorophores, resulting in robust fluorescence resonance energy transfer that can be monitored kinetically in real time. the assay is sensitive, permitting the use of low enzyme concentrations (<0.5 nm), and can be miniaturized for use in 384-well htS mode. the authors further show that this assay is capable of evaluating inhibitor mechanism of action by confirming the binding mechanism of a set of nonnucleoside rt inhibitors. Given the versatility and the lack of requirement for costly platforms or radioactivity, this assay may serve to accelerate and streamline the discovery and characterization process for future antiviral agents. (Journal of Biomolecular Screening 2011;16:518-524) key words: hIV reverse transcriptase, Fret, continuous, homogeneous
T he recent UnAIDS 2009 AIDS epIDemIc UpDAte indicated that as of the end of 2008, approximately 33 million people were living with hIV, with ~2.7 million people becoming infected by the virus every year. 1 Fortunately, as a result of the discovery and the development of potent anti-hIV drug regimens, patients who become infected with hIV today are expected to have a much greater chance of survival against this deadly disease. Yet, despite the vast array of therapies available, the emergence of drug-resistant mutant viruses greatly limits their long-term utility. Another important issue with chronic antiretroviral drug regimes is drug-related side effects. Indeed, both long-term and short-term use of hIV inhibitors is often associated with undesirable side effects 2,3 (i.e., rash, premature aging, lipodystrophy, etc.). thus, there remains an urgent need for the identification of potent and safe anti-hIV drugs with unique mechanisms of action and distinct resistance profiles. most AIDS therapy regimens include at least one inhibitor of the reverse-transcriptase (rt) enzyme. Indeed, nearly half of the approved anti-hIV drugs target the DnA polymerase activity of rt. hIV rt is composed of two subunits originated from the same protein precursor: one subunit contains 440 amino acids (p51), and the second subunit contains 560 amino acids (p66). For the virus to replicate, a viral, single-stranded rnA genome has to be copied into a double-stranded DnA molecule for its further incorporation into the host DnA in order for viral protein expression to take place. to accomplish this complicated task, the enzyme relies on two different active sites both on the p66 subunit; one is responsible for DnA polymerization (polymerase activity), and the second is responsible for the degradation of the rnA template and the trnA primer (rnase h activity) (for an in-depth review of functions of hIV rt, see Sarafianos et al. 4 ).
One key feature for inhibition of hIV rt is the formation of a binding pocket (nonnucleoside inhibitor binding pocket [nnIBp]) close to the polymerase active site of the enzyme that is dependent on the presence of specific compounds (nonnucleoside rt inhibitors [nnrtIs]) best exemplified by efavirenz. nnrtIs are potent polymerase inhibitors and noncompetitive in regard to the incoming dntps or DnA/rnA substrates. Structural data suggest that nnrtI binding locks the conformation of the protein that is no longer able to align the primer terminus in a productive polymerase active site. 4 many different methodologies have been described in the literature for the measurement of hIV rt and other viral polymerases. [5] [6] [7] [8] [9] [10] [11] [12] requirements for the use of radiolabeled substrates, high enzyme concentrations, and/or coupled reactions in some of these assays, however, limit the utility of many of these assays, particularly for high-throughput screening (htS) and/or detailed mechanistic compound-enzyme studies. moreover, in many cases, rt assays are run in an endpoint mode instead of a kinetic mode, which precludes real-time kinetic studies that may be required for enzyme or inhibitor characterization. In the present report, we describe a novel and simple hIV rt polymerase assay based on fluorescence resonance energy transfer (Fret) principles that is sensitive and allows measurement of enzyme activity in a real-time mode for kinetic studies or in an endpoint mode for its use in htS.
mAtErIALS And mEtHodS

HIV reverse transcriptase enzyme assay
hIV rt enzyme for this study was prepared as described previously. 13 custom primer and fluorophore-labeled DnA templates were synthesized at triLink Biotechnologies (San Diego, cA). All necessary dilutions for this assay were done in assay buffer: 50 mm tris, 80 mm Kcl, 6 mm mgcl 2 , 0.025% 3-[(3-cholamidopropyl) dimethylammonio]-1-propane sulfonate (chApS), 1 mm dithiothreitol (Dtt), and 0.1 mm ethylene glycol tetra-acetic acid (eGtA), ph 7.8. Annealing of the primer to the DnA template was done by mixing equal volumes of both complementary oligos at 10 µm in a microtube. the solution was then heated at 90 °c for 3 min and then allowed to slowly cool at room temperature (45-60 min). A mixture of deoxynucleotide triphosphates (A, c, G only) and Alexa Fluor 555 quencher dUtp (cat. A32762; Invitrogen, carlsbad, cA) was prepared at 0.4 µm. the enzymatic reaction was preceded by a 15-min room temperature incubation of 40 nm of the annealed primer/template DnA, 0.1 to 2 nm of hIV reverse transcriptase, and 500 nL of test compounds (or DmSO alone) in a volume of 25 µL. the reaction took place in either a 96-or 384-well plate. the reaction was initiated by adding 25 µL of dntp/quencher dUtp mixture at 0.4 µm. the kinetics of the reaction was followed at room temperature for 20 min on the Spectramax Gemini em (molecular Devices, Sunnyvale, cA), taking measurements every 2 min (or as necessary) with excitation set at 485 nm and emission at 530 nm with a cutoff at 515 nm.
Gel-based primer extension assay
A 5′-cy3-labeled DnA poly-purine tract (ppt)-based primer similar to one previously described 14 was annealed to an unlabeled 47-mer template at a 1:4 (primer:template) ratio. primer extension was initiated by adding 1 µm dntps to 20 nm primer/ template with 500 pm hIV-1 rt enzyme and 6 mm mgcl 2 to a final volume of 20 µL. reactions were stopped by the addition of bromphenol blue-containing formamide (100%). products were resolved on a 12% polyacrylamide 7 m urea gel and visualized using the typhoon (Ge healthcare Life Sciences, piscataway, nJ) gel scanner.
Kinetic analysis
to determine the mode of action of nnrtI compounds, rate of the reaction was measured at various dntp concentrations and various inhibitor concentrations. rate of the reaction was globally fitted using Sigmaplot 10.0 (Systat Software, San Jose, cA) to the following equation:
which describes enzyme velocity for noncompetitive inhibition and assuming the inhibitor binds only to one form of the enzyme.
Data analysis
the Z′ factor was determined from two assay plates: one plate comprising all positive control wells and a second plate comprising all negative control wells (no enzyme) using the regular protocol. enzyme concentration was set at 0.5 nm, and the reactions were run in kinetic mode to measure reaction rates. reaction rates from the wells of each plate were averaged and the standard deviation obtained. Z′ factor was calculated as previously described. 15 rESuLtS And dIScuSSIon to measure polymerase activity of hIV rt, we opted for a short DnA/DnA primer/template substrate with a sequence that was based on the natural ppt sequence found within the hIV genome. the simple design, illustrated in Figure 1 , is such that only three deoxynucleotides are incorporated into the primer strand. In recent work, using a standard scintillation proximity readout of radiolabeled dAtp, we demonstrated that an unlabeled version of the substrate described in this work accurately reported inhibitory potency for a set of nonnucleoside rt inhibitors (A. Auger, S. Zhu, e. cauchon, J.-p. Falgueyret, J.A. Grobler, and r. A. melnyk, unpublished observations). We showed that the potency of various rt inhibitors was the same whether using a substrate allowing only 3 incorporations or one allowing up to 90 incorporations. here, we chose a DnA primer template rather than an rnA primer template as we and others had observed that the specific activity of the polymerase activity is at least one order of magnitude higher when measured with a DnA primer. 16 this allowed us to monitor enzyme activity using low rt concentrations (i.e., ~0.5 nm) and for short incubations (15-60 min) . the advantages of using low enzyme concentrations for screening purposes are twofold: (1) the assay can be used to accurately evaluate the potency of very potent polymerase inhibitors (i.e., potencies as low as Ic 50 ~1 nm), and (2) less enzyme is required per well-a potentially important factor when the assay is used for htS purposes.
recently, a clever Fret-based hIV rt assay was devised to detect incorporation of complementary donor and acceptorlabeled dUtps to a polyA oligo template. 10 Although capable of continuous measurements of hIV rt activity and inhibi-tion, this assay may be limited by sensitivity (i.e., the authors only showed titration curves using 200 nm hIV rt). moreover, as most high-throughput sample collections contain many compounds with conjugated systems that fluoresce in the 300-to 400-nm region, this assay, which uses an excitation of 348 nm, may suffer from compound-related fluorescence interference.
the detection strategy that we used here to measure polymerase activity of hIV rt enzyme was based on the principle that fluorescence from a short primer/template substrate labeled at the 5′ end of the DnA template will be transferred and/or quenched by enzymatic-dependent incorporation of a dUtp molecule coupled to Alexa Fluor 555 ( Fig. 1) . In our initial design, we used a similar Fret pair as that used by parniak and coworkers 17 to measure rnase h activity (i.e., fluorescein donor and dabcyl quencher), except using the more photostable Alexa Fluor 488 (AF488) dye as the donor. to test the potential of this concept, we first synthesized a primer representing a fully polymerized dabcyl-labeled product. As expected, we saw significant quenching (i.e., approximately 5-fold, denoted as * in Fig. 1 ) of donor fluorescence by the dabcyl-labeled primer. In an attempt to increase quenching further and perhaps enable ratiometric measurements of donor quenching and acceptor sensitization, we next synthesized a version of the primer with Alexa Fluor 555 (AF555) as the fluorescent acceptor fluorophore. We chose AF555 for a number of reasons: (1) AF555 has an excitation spectrum that closely overlaps with the emission spectrum of the AF488 donor, (2) AF555 is a stable and a highly fluorescent dye (i.e., extinction coefficient = 155 000 cm −1 m −1 ), and (3) dUtp-AF555 is commercially available, greatly facilitating reagent acquisition. moreover, these dyes are significantly redshifted from most intrinsically fluorescent small-molecule compounds. Annealing the AF555-labeled primer to a donor-labeled template resulted in much greater donor quenching at 530 nm than was observed for dabcyl (i.e., approximately 25-fold, denoted as ** in Fig. 1 ) and produced a concomitant increase of fluorescence at 570 nm due to acceptor sensitization arising from energy transfer. On the basis of the superior quenching observed for AF555 over dabcyl, we carried out all subsequent experiments with the AF488-AF555 Fret pair and monitored loss of signal at 530 nm. Of note, although we did see significant acceptor sensitization in the idealized 100% polymerized proof-of-concept experiment shown in Figure 1 , we found that this signal was not robust enough to follow in routine rt activity assays, where substrate-to-product turnover was much less than 10%. We next performed real-time kinetic measurements of the optimized substrate, comparing the kinetics of the aforementioned 32-deoxynucleotide along with two longer versions of the template that were 41 and 49 deoxynucleotides long, respectively (Fig. 2) . In all three cases, templates were designed to permit only a single incorporation event of acceptor at the 3′-terminus of the primer. As shown in Figure 2A , increasing the length of the template resulted in an apparent decrease in the rate of the substrate is a short DnA/DnA primer/template based on the poly-purine tract (ppt) region from the hIV genome. the template strand is labeled at the 5′-terminus with a donor fluorophore (D), Alexa Fluor 488. polymerization mediated by incubation with reverse transcriptase (rt), dAtp, dGtp, and an acceptor/quencher-labeled dUtp juxtaposes the donor-acceptor/quencher pairs, resulting in donor quenching. Bottom: to test the concept, primers representing fully polymerized products were synthesized and annealed to either unlabeled or donor-labeled templates. excitation was performed at 486 nm in all cases. Annealing a dabcyl-labeled primer to the Alexa Fluor 488 (AF488)labeled template resulted in significant donor quenching (~5-fold), denoted with *. On the other hand, annealing the Alexa Fluor 555 (AF555) acceptor-labeled primer to the AF488-labeled template resulted in ~25-fold quenching of donor signal, denoted with **, and acceptor sensitization at 570 nm. Unlabeled hybrid controls are shown also. polymerization. In fact, for the longest template, a lag phase is apparent ( Fig. 2A, filled circles) . As this could confound initial rate calculations, we elected to stay with the shortest possible template so that the initial rate observed gave a fair estimate of the specific activity of the enzyme. the lag phase observed with a longer template might be a consequence of the time required by the enzyme to reach the end of the template to incorporate the quencher (dUtp Alexa Fluor 555). to address this experimentally and to discriminate between processivity and distributivity of polymerization in our assay, we devised a gel-based primer extension assay using a primer/template that closely mirrored the longest Fret template. In this case, the primer was labeled at the 3′-end with a cy3 dye to visualize DnA elongation on polyacrylamide gel electrophoresis (pAGe). As shown in Figure 3 , only two bands were observed, which correspond to the starting p/t (17 nt on gel) and the fully polymerized p/t (34 of nt on gel). no laddering effect has been observed up to 60 min, which is in agreement with a processive polymerization. this result clearly demonstrates that using a short ppt-based DnA template, it is possible to engage hIV rt in a processive mode.
An important consideration of this assay is the observed sensitivity to DmSO, as shown in Figure 2b . In the presence of 5% of DmSO, the specific activity of rt is reduced by more than 75%. Such high levels of DmSO are not typically required; on the basis of the DmSO titration displayed in Figure 2b , we thus performed the assay using 1% DmSO final concentration (500 nL of DmSO in a final volume of 50 µL). With respect to additives typically used to reduce the effect of nonspecific promiscuous inhibitors, 18 we also investigated the effect of bovine serum albumin (BSA) and triton X-100 on assay performance. For both BSA and triton X-100, there was no significant change in specificity up to 0.1% and 0.01%, respectively (data not shown).
We next conducted experiments to evaluate the ability of the optimized Fret assay to mechanistically characterize inhibitors of rt. classic dose-titration curves for three inhibitors of rt, including the marketed nnrtI efavirenz and two investigational nnrtI inhibitors, were observed ( Fig. 4 ). Using 500 pm of rt, we obtained Ic 50 s of 4 nm, 70 nm, and 103 nm for efavirenz, compound 1, and compound 2, respectively. next, we conducted experiments designed to establish the binding mode of action for inhibitors. to confirm mode of action of the three confirmed nnrtI compounds, the rate of the reaction was measured at various concentrations of dntp (0, 100, 200, 500, 100, 2000 nm) and compounds. rates obtained for each concentration of dntp and inhibitor were globally fit (see materials and methods for equation) to distinguish between competitive, uncompetitive, and noncompetitive modes. Fitted curves are shown in the bottom panels of Figure 4 for efavirenz and compound 1, with the corresponding derived kinetic constants obtained from the fit shown in the top right panel of Figure 4 . each of the compounds showed excellent correlation for noncompetitive inhibition in regard to dntp, with R-square values obtained >0.95 and kinetic constants in agreement with the model. moreover, Ic 50 values correlated very well with K i values obtained through the global fit for every compound tested at the concentration of dntp used in the assay (1 µm), approximately 10-fold higher than the observed K m for dntp (0.14 µm).
Finally, to demonstrate that our Fret assay was compatible for htS, we arrayed positive and negative controls in 384well plates and determined the statistics for the assay (data not shown). In this mode, the assay was robust, with a calculated Z factor value of 0.63 with a coefficient of variation of 7.8% for the positive wells.
In conclusion, a Fret assay was developed to measure hIV rt polymerase activity in real time that could be used for both screening and detailed kinetic and mechanistic characterization of inhibitors of rt. Unlike most other assays of rt, which are typically discontinuous, involve the use of radioactive isotopes for detection, and often require extensive sample handling, FIg. 3 . Gel-based primer extension assay. START: A cy3-labeled poly-purine tract (ppt)-based primer is annealed to a DnA template. At time 0, a single species is observed on a polyacrylamide gel, corresponding to labeled 17-nt primer. FINISH: reverse transcriptase (rt) extends primer in a highly processive manner, as evidenced by a single 34-nt product observed on a polyacrylamide gel. our simple one-pot method is robust, accurate, continuous, and rapid-properties that we anticipate will make this a very useful tool for researchers studying hIV rt activity and inhibition. for the three model nonnucleoside rt inhibitors (nnrtI) compounds used in this study. Top right: Kinetic parameters and R-squared for three nnrtI compounds are shown. the rate of the reaction was measured at various dntp concentrations and various inhibitor concentrations. rate of the reaction was globally fitted with corresponding R-squared for noncompetitive mechanism (see materials and methods). Bottom: effect of inhibitor concentration on enzyme activity at various dntp concentrations to establish inhibitor mechanism of action. the dntp titrations were performed with two different compounds: (left) efavirenz and (right) compound 1. For efavirenz, dntps were titrated at three different inhibitor concentrations (open triangles) 1.5 nm, (filled inverted triangles) 14 nm, (open circles) 41 nm, (filled circles) DmSO), as well as for compound 1 (open triangles) 41 nm, (filled inverted triangles) 123 nm, (open circles) 370 nm, (filled circles) DmSO). Data were globally fitted as described in the method for a noncompetitive mode of action.
